In laboratory and endocrine research settings, the REVITALIZE STACK has been investigated in relation to:
Coordinated growth hormone (GH) pulse stimulation
GHRH and ghrelin receptor pathway interaction
GH–IGF-1 axis regulation and signaling synergy
Endocrine rhythmicity and feedback mechanisms
Sleep-associated GH release patterns
Skeletal, connective tissue, and metabolic research
Comparative and combination GH secretagogue modeling
$ 144.00 Original price was: $ 144.00.$ 129.60Current price is: $ 129.60.
Out of stock
Peptides are not ready to use. Must purchase BAC water for reconstitution.
The REVITALIZE STACK combines CJC-1295 No DAC (a short-acting GHRH analog) with Ipamorelin (a selective ghrelin receptor agonist) to support research into coordinated growth hormone signaling. This combination is commonly used in laboratory studies exploring synergistic GH release, endocrine timing, and GH–IGF-1 axis dynamics. Researchers utilize this stack to investigate pulse-based GH stimulation while maintaining endocrine specificity and avoiding prolonged receptor activation.
Research suggests the combined use of CJC-1295 No DAC and Ipamorelin influences several complementary biological processes related to growth hormone regulation:
Dual-Pathway GH Stimulation
CJC-1295 No DAC activates GHRH receptors in the pituitary, while Ipamorelin stimulates GH release through ghrelin (GHSR-1a) receptors. Together, they provide coordinated upstream signaling to promote endogenous GH secretion.
Physiological GH Pulsatility
Both peptides support short, rhythmic GH pulses rather than continuous stimulation. This allows researchers to study GH patterns that more closely resemble natural endocrine signaling.
GH–IGF-1 Axis Regulation
By increasing endogenous GH output through two distinct receptor pathways, the stack indirectly influences IGF-1 signaling, supporting research into tissue maintenance, metabolism, and anabolic signaling.
Endocrine Specificity & Feedback Control
Ipamorelin’s selective receptor profile minimizes activation of stress-related hormones, while the short-acting nature of CJC-1295 No DAC allows observation of natural somatostatin and feedback responses.
Combination & Comparative Research Models
The REVITALIZE STACK is frequently used in experimental designs evaluating how GHRH analogs and ghrelin agonists interact, offering insight into coordinated endocrine signaling and GH secretagogue synergy.
Elite Bioscience supplies the REVITALIZE STACK strictly for laboratory, analytical, and in-vitro research.
Supplier: Elite Bioscience®
Product Form:
• 1 × 5 mg sterile, lyophilized peptide vial — CJC-1295 No DAC
• 1 × 5 mg sterile, lyophilized peptide vial — Ipamorelin
Active Ingredients:
• CJC-1295 No DAC (Modified GRF 1-29)
• Ipamorelin (NNC 26-0161)
Peptide Classes:
• Synthetic growth hormone–releasing hormone (GHRH) analog
• Selective growth hormone secretagogue (GHS); ghrelin receptor (GHSR-1a) agonist
Research Use:
For laboratory, in-vitro, and analytical research only.
Not for human or veterinary use.